News FocusGenetics

Hopping to a Better Protein

See allHide authors and affiliations

Science  05 Dec 2008:
Vol. 322, Issue 5907, pp. 1454-1455
DOI: 10.1126/science.322.5907.1454

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Clinical trials are under way to test an innovative use of antisense technology to stem paralysis in Duchenne muscular dystrophy.